Back

Circumferential aneurysm wall enhancement predicts recanalization after stent-assisted coiling in small unruptured intracranial aneurysms

Jiang, Q.-Y.; Ruan, X.-L.; Chen, R.; Shi, Z.-S.

2025-06-24 neurology
10.1101/2025.06.24.25330199
Show abstract

BackgroundCircumferential aneurysm wall enhancement (CAWE) on high-resolution vessel wall imaging (HR-VWI) as a vessel wall inflammation marker is associated with the instability of unruptured intracranial aneurysms (UIAs) and recanalization after endovascular treatment. This study evaluates the association of CAWE with recanalization of small UIAs (<10 mm) treated with stent-assisted coiling (SAC) or coiling alone and aims to develop a prediction model for recanalization based on CAWE. MethodsWe analyzed patients with saccular UIAs who underwent 3T HR-VWI and were treated with SAC or coiling alone between October 2018 and May 2024. A 4-grade scale assessed aneurysm wall enhancement (none, focal thick wall enhancement, thin CAWE, thick CAWE). The aneurysm-to-pituitary stalk contrast ratio (CRstalk) quantified enhancement. We investigated the relationship between CAWE and recanalization and developed a recanalization prediction model. ResultsSixty-five patients with 69 small saccular UIAs were included; 11 aneurysms (15.9%) exhibited CAWE, and 10 aneurysms (14.5%) had a CRstalk [&ge;] 0.5. Sixty aneurysms received SAC. Recanalization occurred in 14 of 69 aneurysms (20.3%), assessed by digital subtraction angiography follow-up at 12.6 months. Multivariate analysis revealed that smoking, aneurysm size, CAWE, and CRstalk [&ge;] 0.5 predicted recanalization. A scoring prediction model was created using aneurysm size, treatment, embolization occlusion, and CAWE, with scores ranging from 0 to 6, where scores [&ge;] 3 indicated high risk and a C-statistic of 0.892 demonstrated excellent discrimination. ConclusionsCAWE on HR-VWI is a significant imaging marker for predicting recanalization in small UIAs undergoing SAC. The proposed recanalization risk scale needs further validation in larger studies.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Stroke: Vascular and Interventional Neurology
based on 12 papers
Top 0.1%
22.5%
2
Stroke
based on 29 papers
Top 1%
6.5%
3
Frontiers in Neurology
based on 74 papers
Top 3%
5.3%
4
Neurology
based on 38 papers
Top 2%
5.1%
5
Journal of Stroke and Cerebrovascular Diseases
based on 10 papers
Top 0.4%
4.3%
6
Journal of the Neurological Sciences
based on 14 papers
Top 0.3%
3.2%
7
Scientific Reports
based on 701 papers
Top 47%
3.2%
50% of probability mass above
8
Journal of the American Heart Association
based on 92 papers
Top 6%
3.2%
9
Brain and Behavior
based on 19 papers
Top 0.4%
3.2%
10
PLOS ONE
based on 1737 papers
Top 80%
2.8%
11
Journal of Neurology, Neurosurgery & Psychiatry
based on 26 papers
Top 2%
2.7%
12
Annals of Clinical and Translational Neurology
based on 22 papers
Top 1%
2.7%
13
Journal of Neurology
based on 22 papers
Top 2%
1.8%
14
European Journal of Neurology
based on 20 papers
Top 1%
1.8%
15
BMJ Open
based on 553 papers
Top 42%
1.5%
16
Epilepsia
based on 27 papers
Top 1%
1.5%
17
Brain
based on 69 papers
Top 6%
0.9%
18
Journal of Clinical Medicine
based on 77 papers
Top 14%
0.9%
19
Nature Communications
based on 483 papers
Top 38%
0.9%
20
Clinical Neurophysiology
based on 19 papers
Top 2%
0.8%
21
Multiple Sclerosis Journal
based on 15 papers
Top 0.8%
0.8%
22
Journal of the American College of Cardiology
based on 11 papers
Top 3%
0.8%
23
Orphanet Journal of Rare Diseases
based on 15 papers
Top 2%
0.8%